These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 32969022

  • 1. Cannabidiol in conjunction with clobazam: analysis of four randomized controlled trials.
    Gunning B, Mazurkiewicz-Bełdzińska M, Chin RFM, Bhathal H, Nortvedt C, Dunayevich E, Checketts D.
    Acta Neurol Scand; 2021 Feb; 143(2):154-163. PubMed ID: 32969022
    [Abstract] [Full Text] [Related]

  • 2. Retrospective chart review study of use of cannabidiol (CBD) independent of concomitant clobazam use in patients with Lennox-Gastaut syndrome or Dravet syndrome.
    Nabbout R, Arzimanoglou A, Auvin S, Berquin P, Desurkar A, Fuller D, Nortvedt C, Pulitano P, Rosati A, Soto V, Villanueva V, Cross JH.
    Seizure; 2023 Aug; 110():78-85. PubMed ID: 37331197
    [Abstract] [Full Text] [Related]

  • 3. Cannabidiol efficacy independent of clobazam: Meta-analysis of four randomized controlled trials.
    Devinsky O, Thiele EA, Wright S, Checketts D, Morrison G, Dunayevich E, Knappertz V.
    Acta Neurol Scand; 2020 Dec; 142(6):531-540. PubMed ID: 32592183
    [Abstract] [Full Text] [Related]

  • 4. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis.
    Talwar A, Estes E, Aparasu R, Reddy DS.
    Exp Neurol; 2023 Jan; 359():114238. PubMed ID: 36206805
    [Abstract] [Full Text] [Related]

  • 5. Long-term safety and efficacy of cannabidiol in children and adults with treatment resistant Lennox-Gastaut syndrome or Dravet syndrome: Expanded access program results.
    Laux LC, Bebin EM, Checketts D, Chez M, Flamini R, Marsh ED, Miller I, Nichol K, Park Y, Segal E, Seltzer L, Szaflarski JP, Thiele EA, Weinstock A, CBD EAP study group.
    Epilepsy Res; 2019 Aug; 154():13-20. PubMed ID: 31022635
    [Abstract] [Full Text] [Related]

  • 6. Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trials.
    Bialer M, Perucca E.
    Epilepsia; 2020 Jun; 61(6):1082-1089. PubMed ID: 32452568
    [Abstract] [Full Text] [Related]

  • 7. Cannabidiol for the treatment of Lennox-Gastaut syndrome and Dravet syndrome: experts' recommendations for its use in clinical practice in Spain.
    García-Peñas JJ, Gil Nagel-Rein A, Sánchez-Carpintero R, Villanueva-Haba V.
    Rev Neurol; 2021 Sep 10; 73(S01):S1-S8. PubMed ID: 34486101
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis.
    Lattanzi S, Brigo F, Trinka E, Zaccara G, Cagnetti C, Del Giovane C, Silvestrini M.
    Drugs; 2018 Nov 10; 78(17):1791-1804. PubMed ID: 30390221
    [Abstract] [Full Text] [Related]

  • 9. Caregiver-reported outcomes with real-world use of cannabidiol in Lennox-Gastaut syndrome and Dravet syndrome from the BECOME survey.
    Berg AT, Dixon-Salazar T, Meskis MA, Danese SR, Le NMD, Perry MS.
    Epilepsy Res; 2024 Feb 10; 200():107280. PubMed ID: 38183688
    [Abstract] [Full Text] [Related]

  • 10. New therapeutic approach in Dravet syndrome and Lennox-Gastaut syndrome with cannabidiol.
    Villanueva V, Carreño-Martínez M, Gil Nagel-Rein A, López-González FJ.
    Rev Neurol; 2021 Apr 30; 72(S01):S1-S10. PubMed ID: 33908026
    [Abstract] [Full Text] [Related]

  • 11. Cannabidiol efficacy and clobazam status: A systematic review and meta-analysis.
    Lattanzi S, Trinka E, Striano P, Zaccara G, Del Giovane C, Nardone R, Silvestrini M, Brigo F.
    Epilepsia; 2020 Jun 30; 61(6):1090-1098. PubMed ID: 32452532
    [Abstract] [Full Text] [Related]

  • 12. Clinical implications of trials investigating drug-drug interactions between cannabidiol and enzyme inducers or inhibitors or common antiseizure drugs.
    Patsalos PN, Szaflarski JP, Gidal B, VanLandingham K, Critchley D, Morrison G.
    Epilepsia; 2020 Sep 30; 61(9):1854-1868. PubMed ID: 32918835
    [Abstract] [Full Text] [Related]

  • 13. Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox-Gastaut Syndrome.
    Lattanzi S, Trinka E, Striano P, Rocchi C, Salvemini S, Silvestrini M, Brigo F.
    CNS Drugs; 2021 Mar 30; 35(3):265-281. PubMed ID: 33754312
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological and Therapeutic Properties of Cannabidiol for Epilepsy.
    Franco V, Perucca E.
    Drugs; 2019 Sep 30; 79(13):1435-1454. PubMed ID: 31372958
    [Abstract] [Full Text] [Related]

  • 15. Consensus panel recommendations for the optimization of EPIDIOLEX® treatment for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex.
    Wechsler RT, Burdette DE, Gidal BE, Hyslop A, McGoldrick PE, Thiele EA, Valeriano J.
    Epilepsia Open; 2024 Oct 30; 9(5):1632-1642. PubMed ID: 39007525
    [Abstract] [Full Text] [Related]

  • 16. Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial.
    Patel AD, Mazurkiewicz-Bełdzińska M, Chin RF, Gil-Nagel A, Gunning B, Halford JJ, Mitchell W, Scott Perry M, Thiele EA, Weinstock A, Dunayevich E, Checketts D, Devinsky O.
    Epilepsia; 2021 Sep 30; 62(9):2228-2239. PubMed ID: 34287833
    [Abstract] [Full Text] [Related]

  • 17. Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.
    Perry MS.
    Epilepsy Curr; 2019 Sep 30; 19(2):93-95. PubMed ID: 30955420
    [Abstract] [Full Text] [Related]

  • 18. Practical use of pharmaceutically purified oral cannabidiol in Dravet syndrome and Lennox-Gastaut syndrome.
    Lattanzi S, Zaccara G, Russo E, La Neve A, Lodi MAM, Striano P.
    Expert Rev Neurother; 2021 Jan 30; 21(1):99-110. PubMed ID: 33026899
    [Abstract] [Full Text] [Related]

  • 19. Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.
    Hussain SA, Zhou R, Jacobson C, Weng J, Cheng E, Lay J, Hung P, Lerner JT, Sankar R.
    Epilepsy Behav; 2015 Jun 30; 47():138-41. PubMed ID: 25935511
    [Abstract] [Full Text] [Related]

  • 20. Anti-seizure medications for Lennox-Gastaut syndrome.
    Brigo F, Jones K, Eltze C, Matricardi S.
    Cochrane Database Syst Rev; 2021 Apr 07; 4(4):CD003277. PubMed ID: 33825230
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.